Sugar Maple Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,800
Closed -$439K 84
2026
Q1
$439K Sell
6,800
-6,000
-47% -$423K 0.27% 55
2025
Q4
$861K Buy
12,800
+2,500
+24% +$168K 0.58% 36
2025
Q3
$755K Sell
10,300
-4,000
-28% -$266K 0.54% 37
2025
Q2
$744K Buy
14,300
+4,000
+39% +$228K 0.58% 33
2025
Q1
$657K Buy
10,300
+2,500
+32% +$145K 0.52% 35
2024
Q4
$373K Buy
+7,800
New +$400K 0.28% 44

Other funds holding HALO

Sugar Maple Asset Management's HALO Position: Q2 2026 in Review

Sugar Maple Asset Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 6,800 shares — an estimated $439K sold.

Sugar Maple Asset Management first reported a position in HALO in Q4 2024 and held it in 6 quarters. The position peaked at $861K in Q4 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Sugar Maple Asset Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Sugar Maple Asset Management sold 6,800 Halozyme shares in Q2 2026, an estimated $439K.
  • Sugar Maple Asset Management first reported a position in Halozyme in Q4 2024 and held it in 6 quarters.
  • Sugar Maple Asset Management's Halozyme position peaked at $861K in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Sugar Maple Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.